Swiss Economicblogs.org
Der Pharmakonzern Roche will bei der Entwicklung seiner Medikamente gegen Diabetes und Fettleibigkeit Tempo machen.
Read More »Roche erleidet erneut Rücksetzer mit neuartiger Krebstherapie
Der Pharmakonzern Roche hat einmal mehr eine Forschungsschlappe erlitten. Die Aktie steht nach der Enttäuschung unter Druck.
Read More »Drei Schweizer unter den 100 wertvollsten Unternehmen
Tech rules - Technologieunternehmen führen unangefochten die Rangliste der am höchsten bewerteten Börsenunternehmen der Welt an. Besonders der KI-Boom gab der Branche einen neuen Schub. Aber auch drei bekannte Schweizer Unternehmen haben es unter die Top 100 geschafft.
Read More »Swiss firms give over CHF5 million a year to parties and candidates
Switzerland is the only country among the 47 members of the Council of Europe which does not have a law governing political party financing. (© Keystone / Gaetan Bally) Switzerland’s biggest firms – mainly banks, pharmaceutical firms and insurance companies – donate at least CHF5 million ($5 million) a year to political parties and candidates, a survey has revealed. The poll of 140 companies by Swiss public radio RTS, published on Tuesdayexternal link, found that one...
Read More »Roche sees its first cancer immunotherapy winning U.S. nod soon
Brought to you by Investec Switzerland. Roche Holding AG said its most advanced experimental drug to harness the immune system in the fight against cancer may win U.S. regulatory approval this year, becoming the first such treatment to help the roughly 430,000 people diagnosed annually with bladder cancer. © Daniel Schreurs | Dreamstime.com The medicine, called atezolizumab, may generate around $3 billion in sales by 2020, according to Bloomberg Intelligence. It will face competition from...
Read More »